In a report released today, Michael Pachter from Wedbush maintained a Buy rating on Zynga (NASDAQ: ZNGA), with a price target of $5.50.
Wedbush analyst Michael Pachter maintained a Buy rating on Activision Blizzard (NASDAQ: ATVI) today and set a price target of $81. The company’s …
Wedbush analyst Michael Pachter upgraded Take-Two (NASDAQ: TTWO) to Buy today and set a price target of $126. The company’s shares closed on …
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nektar Therapeutics (NASDAQ: NKTR), Biospecifics …
Today, the CEO & President of Hemispherx Biopharma (NYSE MKT: HEB), Thomas Equels, bought shares of HEB for $10.24K.
Boenning & Scattergood analyst Floris van Dijkum reiterated a Sell rating on CBL and Associates (NYSE: CBL) today and set a price target …
In a report released today, Sam Poser from Susquehanna maintained a Hold rating on Genesco Inc (NYSE: GCO), with a price target of …
Ventas (NYSE: VTR) was upgraded from Buy to Sell rating and received a $53 price target from BMO Capital analyst John Kim today. The …
In a report issued on April 26, Stephen Anderson from Maxim Group maintained a Buy rating on Cheesecake Factory (NASDAQ: CAKE), with a …
In a report released today, Michael Matson from Needham reiterated a Buy rating on Hill-Rom (NYSE: HRC), with a price target of $106. …
